CellWell record HH-48676
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice
Sabrina Chiloiro; Maria Grazia Maratta; Simone Antonio De Sanctis; Flavia Costanza; Ernesto Rossi; Emanuele Vita; Antonella Giampietro; Francesco Pavese; Olga Martelli; Ida Paris; Antonio Bianchi; Giovanni Schinzari; Laura De Marinis; Anna Fagotti; Giampaolo Tortora; Alfredo Pontecorvi
2026
In plain language
This review found that combined immune checkpoint inhibitor and tyrosine kinase inhibitor cancer treatments can cause endocrine side effects including thyroid dysfunction, adrenal insufficiency, and diabetes, requiring early multidisciplinary monitoring.
- Evidence
- Established
- Design
- Systematic review
Cite this record: https://thecellwell.org/studies/HH-48676
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.